Nasal desmopressin (DDAVP, Stimate, etc) is no longer approved for bedwetting

January 2008

See updated information on this topic from Health Canada

Nasal desmopressin (DDAVP, Stimate, etc) is no longer approved for bedwetting...due to reports of serious hyponatremia.

Most of these cases occur in children using the nasal formulations for bedwetting...probably because dosing errors are more common with the nasal form than the tablets.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

Cutting-edge advice about new medications and how they fit into practice
Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

The DEA now allows you to write multiple Schedule II (C-II) Rxs on the same day, for the same patient and drug
Cardiology whether a beta-blocker should be started before noncardiac surgery
Psychiatry Abilify (aripiprazole) is the first antipsychotic approved for major depressive disorder
Neurology & Pain Voltaren Gel and Flector Patch will be the first TOPICAL Rx NSAIDs to be commercially available for pain
Diabetes The new Symlin (pramlintide) pen will help reduce errors
Alcohol whether they can drink alcohol with their medications
Women's Health More women will get shorter courses of nitrofurantoin for uncomplicated bladder infections
Renal & Urology Sanctura XR, a new long-acting formulation of trospium, will soon be another option for treating overactive bladder
Respiratory & Allergy Many patients are getting both Spiriva and ipratropium together
Respiratory & Allergy Cetirizine (Zyrtec, Zyrtec-D) will soon be available OTC
Respiratory & Allergy alternatives to traditional OTC cough and cold medicines for infants and young children
Diabetes & Endocrinology Nasal desmopressin (DDAVP, Stimate, etc) is no longer approved for bedwetting
Vaccines New rules will help clarify Medicare Part D billing for Zostavax (zoster vaccine)

Nasal desmopressin (DDAVP, Stimate, etc) is no longer approved for bedwetting

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Table of Contents